Delphi VC
VC Fund
New York, United States
Delphi VC is a VC fund in New York focused on Health Care and FinTech. Delphi is dedicated to supporting the next generation of World-Positive founders with support, advice, and capital. Delphi invests in early-stage and late-stage companies and teams that hold promise to transform old-line industries with new, sustainable solutions.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Delphi VC invests in
Stages Delphi VC invests in
Countries Delphi VC invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $25M–$40M
- Series B
- $26M–$80M
Investment Focus
Industry
- Health Care 6 (43%)
- FinTech 3 (21%)
- Wellness 3 (21%)
- Biotechnology 3 (21%)
- Medical 2 (14%)
Stage
- Seed 3 (21%)
- Series A 3 (21%)
- Series B 3 (21%)
- Convertible Note 2 (14%)
- Venture - Series Unknown 2 (14%)
Country
- United States 11 (79%)
- Colombia 1 (7%)
- United Kingdom 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Kalika Farmer
General Partner
|
General Partner | Total investments: 0 | Find email | |
Pip Deely
General Partner
|
General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is todevelop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age. | Convertible Note / Jun 02, 2023 | ||
| Rose Los Angeles is a manufacturing company that specializes in producing flower rosin from the cannabis flower. | Seed / Jun 01, 2023 | ||
| Transcend Therapeutics is a clinical-stage biotechnology company focused on developing rapid-acting treatments for neuropsychiatric diseases. The company aims to address mental health conditions such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), particularly for patients who do not respond to existing therapies. Thecompany’s lead program, TSND-201 (methylone), is being developed as a next-generation neuroplastogen designed to deliver fast and durable therapeutic effects. Its research emphasizes innovative psychoactive compounds that can improve outcomes while minimizing common limitations of traditional psychiatric medications. Backed by venture funding and an experienced leadership team with multiple FDA approvals, Transcend Therapeutics continues to advance clinical trials and expand its pipeline of mental health treatments. | $40M / Series A / Feb 23, 2023 | ||
| Everything you need to know about the future of financial inclusion through rental property management. We solve the iconic Edgar Vivar character Señor Barriga in El Chavo del 8 Show main problem: -Rent collection. | $150K / Angel / Sep 07, 2022 | ||
| Journey Colab pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. Their first compound in development is mescaline. It was founded in 2020 and is based in San Francisco, California. | $15.7M / Venture - Series Unknown / Nov 01, 2021 | ||
| Mindbloom is a mental health and wellbeing brand helping people achieve personal and clinical breakthroughs with at-home, clinician-prescribed psychedelic therapies. The company provides science-backed medicine designed by leading psychiatrists and facilitated by friendly, expert guides. | Series B / Sep 01, 2021 | ||
| Smallhold is a farming technology company that provides automated, modular remotely-managed, and subscription-based growing systems. With Smallhold's controlled-environment growing systems, food industry professionals can generate consistent and reliable local produce tailored to their individual business or menu needs independent of climaticchanges or outside market pressures. | $25M / Series A / Aug 20, 2021 | ||
| Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assistindividuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need. | $80.4M / Series B / Aug 15, 2021 | ||
| Caravan Wellness provides corporate wellness programs, online education solutions, social media campaigns, impact tracking, exclusive digital content, brand partnerships, cross industry partnerships, influencers, affiliates, success, nutrition, wellness, yoga, meditation, fitness, productivity, confidence, results, sleep, mindfulness, and employeewellness. | Venture - Series Unknown / Jan 01, 2021 | ||
| Parsley Health is a new kind of healthcare service that integrates technology, nutrition, wellness and prevention into cutting-edge primary care. The company was founded in 2016 by Dr. Robin Berzin, M.D., a Columbia-trained physician, digital health expert and leader in functional medicine. Parsley clinics are currently open in Los Angeles, NewYork City and San Francisco. Learn more at www.parsleyhealth.com | $26M / Series B / Oct 10, 2019 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Delphi VC invest in?
Delphi VC invests primarily in Health Care, FinTech and Wellness startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Delphi VC's check size?
Delphi VC typically joins rounds of $25M–$40M at Series A and $26M–$80M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Delphi VC participates in.
How do I contact Delphi VC?
Public channels for Delphi VC include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Delphi VC?
The team at Delphi VC includes Kalika Farmer (General Partner) and Pip Deely (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
